宏源药业 (301246)
Hubei Hongyuan Pharmaceutical Technology Co.,Ltd.
K-Line Chart
No K-line data
Stock Details
1. Key Indicators
- Total Shares(W): 40000.68
- Circulating A-Shares(W): 16004.28
- Earnings Per Share(RMB): -0.0028
- Net Assets Per Share(RMB): 10.8384
- Operating Revenue(W RMB): 131707.61
- Total Profit(W RMB): 519.63
- Net Profit Attributable to Parent(W RMB): -110.02
- Net Profit Growth Rate(%): -103.04
- Weighted Return on Equity(%): -0.0300
- Operating Cash Flow Per Share(RMB): -0.4640
- Undistributed Profit Per Share(RMB): 4.0355
- Capital Reserve Per Share(RMB): 5.4310
2. Main Business
The main business covers:
- R&D, production, and sales of organic chemical raw materials
- R&D, production, and sales of pharmaceutical intermediates
- R&D, production, and sales of active pharmaceutical ingredients (APIs)
- R&D, production, and sales of new energy and pharmaceutical preparations
3. Company Basic Information
- Company Name: Hubei Hongyuan Pharmaceutical Technology Co., Ltd.
- Listing Date: 2023-03-20
- Industry: Pharmaceutical Manufacturing
- Address: No. 8 Hongyuan Road, Economic Development Zone, Fengshan Town, Luotian County, Hubei Province, China
- Website: www.hbhypharm.com
- Company Profile: The company was formerly known as Hongyuan Co., Ltd. It was approved to change to a joint-stock company at a shareholders' meeting on February 24, 2014, and completed its industrial and commercial registration on April 8, 2014. The company is primarily engaged in the R&D, production, and sales of organic chemical raw materials, pharmaceutical intermediates, APIs, new energy, and pharmaceutical preparations.
4. Top 10 Circulating Shareholders
| Rank | Institution Name | Institution Type | Shares Held (W) | Percentage Held (%) |
|---|---|---|---|---|
| 1 | Zhejiang Aobei Investment Management Co., Ltd. | General Legal Person | 200.61 | 1.25 |
| 2 | Hong Kong Securities Clearing Company Ltd. | Northbound Capital | 110.09 | 0.69 |
| 3 | Jointown Pharmaceutical Group Co., Ltd. | General Legal Person | 105.00 | 0.66 |
5. Concept Sectors
- Lithium Battery
- Solid-State Battery
- Synthetic Biology
- Margin Trading & Securities Lending
- Active Stock
- High P/E Ratio
- High Turnover
- Below IPO Price
- Increased Margin Financing
- Recent Market Sentiment
Remarks
- Data update date: 2026-01-01
- Data source: Public Market Information